EEOÜ PharmaEight
About the company
The company OÜ PharmaEight (reg. no. 14915163) was registered on 18.02.2020. Registered address: Harju maakond, Tallinn, Mustamäe linnaosa, Akadeemia tee 45. Main industry: Wholesale and retail trade. In 2025, revenue was 4 902 130 EUR and profit -14 785 EUR. Revenue change compared with 2024: +121,4%. Employees: 5 (2025). The company is a registered VAT payer. Regmio risk score: 86 out of 100 — low risk.
Financials by year
| Year | Turnover | Net profit | Employees |
|---|---|---|---|
| 2025 | 4 902 130 EUR | -14 785 EUR | 5 |
| 2024 | 2 214 022 EUR | 7 537 EUR | 3 |
| 2023 | 2 757 881 EUR | -72 016 EUR | 4 |
| 2022 | 2 748 728 EUR | -128 954 EUR | 4 |
| 2021 | 2 415 015 EUR | 6 767 EUR | 2 |
| 2020 | 1 668 261 EUR | -246 546 EUR | 2 |
Activity
47731 Ravimite jaemüük
Frequently asked questions about OÜ PharmaEight
When was OÜ PharmaEight registered?
OÜ PharmaEight was registered on 18.02.2020, registration number 14915163.
Is OÜ PharmaEight active?
Yes, according to the register the company is active (not removed from the register).
What is the registered address of OÜ PharmaEight?
Registered address: Harju maakond, Tallinn, Mustamäe linnaosa, Akadeemia tee 45.
Is OÜ PharmaEight VAT registered?
Yes, VAT number: EE102233681. Validity for cross-border transactions can be checked in EC VIES.
What does OÜ PharmaEight do?
Main industry: Wholesale and retail trade.
What is the turnover of OÜ PharmaEight?
In 2025, revenue was 4 902 130 EUR.
How many employees does OÜ PharmaEight have?
Employees: 5 (2025).
Who manages and owns OÜ PharmaEight?
The registers list 2 officers and 2 owners or beneficial owners. Names and shares are in the full profile.
Full profile available after login
Free account — 3 full profiles per month. Log in with an e-mail code, no password.
- Board and authorised representatives 2
- Owners and beneficial owners 2
- Financial indicators 6
- Tax and VAT
- Legal events and restrictions
- Timeline 21
Data from official public registers · updated 15.11.2026. Data sources and disclaimer